Pliant Therapeutics Stock

pliantrx.comHealthcare / BioTech & PharmaFounded: 2016Funding to Date: $187MM

Pliant Therapeutics is focused on discovering, developing and commercializing breakthrough treatments for fibrotic diseases.

Register To Buy and Sell Shares

For more details on private stock price information, financing and valuation for Pliant Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Pliant Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Pliant Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Bernard Coulie MD
Chief Executive Officer, President & Board Member
Hans Hull JD
Chief Business Officer
Dean Sheppard MD
Scientific Founder and Scientific Advisor, Translational Medicine
Barbara Howes
Chief Human Resources Officer
Éric Lefebvre MD
Chief Medical Officer
Hal Chapman MD
Scientific Founder and Scientific Advisor, Translational Medicine
Keith Cummings MD
Chief Financial Officer
Rik Derynck Ph.D
Scientific Co-Founder & Scientific Advisor of Biology
William DeGrado Ph.D
Scientific Founder

Board Members

John Curnutte MD
Neil Exter
Third Rock Ventures
Hoyoung Huh Ph.D
Kevin Raidy
Cowen Group
Suzanne Bruhn Ph.D
Craig Muir
Third Rock Ventures
Smital Shah
Charles Homcy MD
Third Rock Ventures

Pliant Therapeutics’ stock FAQs


Can you buy Pliant Therapeutics’ stock?

As Pliant Therapeutics is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Pliant Therapeutics, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge's Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy Pliant Therapeutics’ stock?

To invest in a private company like Pliant Therapeutics’ through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)
  1. Create a free account to access Forge's marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Pliant Therapeutics’ stock?

Yes, you may be able to sell your Pliant Therapeutics’ stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell Pliant Therapeutics’ stock?

If you hold private company shares of Pliant Therapeutics’ - whether as an employee or an early investor - Forge can help you sell them.
  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your Pliant Therapeutics’ on our platform.
  3. Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.

Is Pliant Therapeutics’ a public company?

No, Pliant Therapeutics’ is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Pliant Therapeutics’ stock price?

Pliant Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access Pliant Therapeutics’ private market stock price with Forge Data.

What is Pliant Therapeutics’ stock ticker symbol?

Pliant Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Novartis bets $80M on Pliant's preclinical NASH prospect

Novartis has put up $80 million to land the global license to Pliant Therapeutics’ preclinical nonalcoholic steatohepatitis (NASH) asset and three additional candidates. The NASH drug, PLN-1474, is a small molecule inhibitor of integrin αVβ1 Pliant thinks can reduce the growth of fibrotic tissue in the liver.
Updated on: Jul 24, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.